Related Experiment Video
Updated: Jul 10, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Current molecular design of intelligent drugs and imaging probes targeting tumor-specific microenvironments
Kazuhito Tanabe1, Zhouen Zhang, Takeo Ito
1Department of Energy and Hydrocarbon Chemistry, Graduate School of Engineering, Kyoto University, Katsura Campus, Kyoto 615-8510, Japan.
Abstract:
To address the specific challenges of cancer therapy and diagnosis, a number of approaches have been advocated for the development of tumor-targeting antitumor drugs/prodrugs and non-invasive tumor molecular imaging probes. These intelligent drugs and probes are constructed from multi-functional molecular systems. This review focuses on the molecular design of drugs and imaging probes that target tumor-specific microenvironments such as angiogenesis and hypoxia.
Insights
This review explores intelligent, multi-functional molecular systems for advanced cancer therapy and diagnosis. It focuses on designing tumor-targeting drugs and imaging probes that exploit tumor microenvironments like angiogenesis and hypoxia.
Area of Science:
- Oncology
- Molecular Imaging
- Drug Development
Background:
- Cancer therapy and diagnosis face challenges requiring novel approaches.
- Intelligent drugs and imaging probes offer potential solutions.
- Multi-functional molecular systems are key to developing these agents.
Purpose of the Study:
- To review the molecular design of tumor-targeting drugs and imaging probes.
- To highlight strategies for targeting tumor-specific microenvironments.
- To discuss applications in cancer therapy and diagnosis.
Main Methods:
- Literature review of molecular design principles.
- Analysis of multi-functional systems for drug delivery and imaging.
- Focus on targeting tumor microenvironments (angiogenesis, hypoxia).
Main Results:
- Intelligent drugs and probes leverage multi-functional molecular systems.
- Targeting tumor-specific microenvironments like angiogenesis and hypoxia is crucial.
- These agents show promise for improved cancer therapy and diagnosis.
Conclusions:
- Molecular design is critical for developing effective tumor-targeting agents.
- Exploiting tumor microenvironments enhances drug and probe specificity.
- This approach advances cancer treatment and non-invasive molecular imaging.
More Related Videos
12:09A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics
Published on: June 16, 2013
08:52Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice
Published on: January 19, 2018
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Modified-Release Drug Delivery Systems: Site-Targeted